Application 202645

Type
ANDA
Sponsor
ACTAVIS LABS FL INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PALIPERIDONEPALIPERIDONETABLET, EXTENDED RELEASE;ORAL1.5MGNoNo
002PALIPERIDONEPALIPERIDONETABLET, EXTENDED RELEASE;ORAL3MGNoNo
003PALIPERIDONEPALIPERIDONETABLET, EXTENDED RELEASE;ORAL6MGNoNo
004PALIPERIDONEPALIPERIDONETABLET, EXTENDED RELEASE;ORAL9MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0591-3692PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3692PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3692PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3692PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3693PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3693PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3693PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3693PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3694PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3694PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3694PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3694PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3695PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3695PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3695PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
0591-3695PaliperidonePaliperidoneActavis Pharma, Inc.ANDACurrent
68151-5041PaliperidonePaliperidoneCarilion Materials ManagementANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
10089ORIG2015-08-06